Amplicon profiles in ovarian serous carcinomas

Kentaro Nakayama, Naomi Nakayama, Natini Jinawath, Ritu Salani, Robert J Kurman, Ie Ming Shih, Tian-Li Wang

Research output: Contribution to journalArticle

Abstract

Ovarian serous carcinoma is the most common and lethal type of ovarian cancer and its molecular etiology remains poorly understood. As an ongoing effort to elucidate the pathogenesis of ovarian serous carcinomas, we assessed the DNA copy number changes in 33 high-grade serous carcinomas and 10 low-grade serous tumors by using a genome-wide technique, single nucleotide polymorphism array, performed on affinity-purified tumor cells from fresh surgical specimens. Compared to low-grade tumors, high-grade serous carcinomas showed widespread DNA copy number changes. The most frequent alterations were in loci harboring candidate oncogenes: cyclin E1 (CCNE1), AKT2, Notch3 and PIK3CA as well as in novel loci, including 12p13, 8q24, 12p13 and 12q15. Seven amplicons were selected for dual color fluorescence in situ hybridization analysis in ∼90 high-grade serous carcinomas and 26 low-grade serous tumors, and a high level of DNA copy number gain (amplification) was found in CCNE1, Notch3, HBXAP/Rsf-1, AKT2, PIK3CA and chr12p13 occurring in 36.1%, 7.8%, 15.7%, 13.6%, 10.8% and 7.3% of high-grade serous carcinomas. In contrast, we did not observe high level of ERBB2 amplification in any of the samples. Low-grade tumors did not show DNA copy number gain in any of the loci, except in 2 (8%) of 24 low-grade tumors showing low copy number gain in the Notch3 locus. Taken together, our results provide the first comprehensive analysis of DNA copy number changes in highly pure ovarian serous carcinoma. These findings may have important biological and clinical implications.

Original languageEnglish (US)
Pages (from-to)2613-2617
Number of pages5
JournalInternational Journal of Cancer
Volume120
Issue number12
DOIs
StatePublished - Jun 15 2007

Fingerprint

Carcinoma
DNA Copy Number Variations
Neoplasms
Cyclins
DNA
Fluorescence In Situ Hybridization
Oncogenes
Ovarian Neoplasms
Single Nucleotide Polymorphism
Color
Genome

Keywords

  • Amplification
  • Genetics
  • Karyotyping
  • Oncogene
  • Ovarian cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Amplicon profiles in ovarian serous carcinomas. / Nakayama, Kentaro; Nakayama, Naomi; Jinawath, Natini; Salani, Ritu; Kurman, Robert J; Shih, Ie Ming; Wang, Tian-Li.

In: International Journal of Cancer, Vol. 120, No. 12, 15.06.2007, p. 2613-2617.

Research output: Contribution to journalArticle

Nakayama K, Nakayama N, Jinawath N, Salani R, Kurman RJ, Shih IM et al. Amplicon profiles in ovarian serous carcinomas. International Journal of Cancer. 2007 Jun 15;120(12):2613-2617. https://doi.org/10.1002/ijc.22609
Nakayama, Kentaro ; Nakayama, Naomi ; Jinawath, Natini ; Salani, Ritu ; Kurman, Robert J ; Shih, Ie Ming ; Wang, Tian-Li. / Amplicon profiles in ovarian serous carcinomas. In: International Journal of Cancer. 2007 ; Vol. 120, No. 12. pp. 2613-2617.
@article{2881a734cce24e6b8a50843792ca5934,
title = "Amplicon profiles in ovarian serous carcinomas",
abstract = "Ovarian serous carcinoma is the most common and lethal type of ovarian cancer and its molecular etiology remains poorly understood. As an ongoing effort to elucidate the pathogenesis of ovarian serous carcinomas, we assessed the DNA copy number changes in 33 high-grade serous carcinomas and 10 low-grade serous tumors by using a genome-wide technique, single nucleotide polymorphism array, performed on affinity-purified tumor cells from fresh surgical specimens. Compared to low-grade tumors, high-grade serous carcinomas showed widespread DNA copy number changes. The most frequent alterations were in loci harboring candidate oncogenes: cyclin E1 (CCNE1), AKT2, Notch3 and PIK3CA as well as in novel loci, including 12p13, 8q24, 12p13 and 12q15. Seven amplicons were selected for dual color fluorescence in situ hybridization analysis in ∼90 high-grade serous carcinomas and 26 low-grade serous tumors, and a high level of DNA copy number gain (amplification) was found in CCNE1, Notch3, HBXAP/Rsf-1, AKT2, PIK3CA and chr12p13 occurring in 36.1{\%}, 7.8{\%}, 15.7{\%}, 13.6{\%}, 10.8{\%} and 7.3{\%} of high-grade serous carcinomas. In contrast, we did not observe high level of ERBB2 amplification in any of the samples. Low-grade tumors did not show DNA copy number gain in any of the loci, except in 2 (8{\%}) of 24 low-grade tumors showing low copy number gain in the Notch3 locus. Taken together, our results provide the first comprehensive analysis of DNA copy number changes in highly pure ovarian serous carcinoma. These findings may have important biological and clinical implications.",
keywords = "Amplification, Genetics, Karyotyping, Oncogene, Ovarian cancer",
author = "Kentaro Nakayama and Naomi Nakayama and Natini Jinawath and Ritu Salani and Kurman, {Robert J} and Shih, {Ie Ming} and Tian-Li Wang",
year = "2007",
month = "6",
day = "15",
doi = "10.1002/ijc.22609",
language = "English (US)",
volume = "120",
pages = "2613--2617",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "12",

}

TY - JOUR

T1 - Amplicon profiles in ovarian serous carcinomas

AU - Nakayama, Kentaro

AU - Nakayama, Naomi

AU - Jinawath, Natini

AU - Salani, Ritu

AU - Kurman, Robert J

AU - Shih, Ie Ming

AU - Wang, Tian-Li

PY - 2007/6/15

Y1 - 2007/6/15

N2 - Ovarian serous carcinoma is the most common and lethal type of ovarian cancer and its molecular etiology remains poorly understood. As an ongoing effort to elucidate the pathogenesis of ovarian serous carcinomas, we assessed the DNA copy number changes in 33 high-grade serous carcinomas and 10 low-grade serous tumors by using a genome-wide technique, single nucleotide polymorphism array, performed on affinity-purified tumor cells from fresh surgical specimens. Compared to low-grade tumors, high-grade serous carcinomas showed widespread DNA copy number changes. The most frequent alterations were in loci harboring candidate oncogenes: cyclin E1 (CCNE1), AKT2, Notch3 and PIK3CA as well as in novel loci, including 12p13, 8q24, 12p13 and 12q15. Seven amplicons were selected for dual color fluorescence in situ hybridization analysis in ∼90 high-grade serous carcinomas and 26 low-grade serous tumors, and a high level of DNA copy number gain (amplification) was found in CCNE1, Notch3, HBXAP/Rsf-1, AKT2, PIK3CA and chr12p13 occurring in 36.1%, 7.8%, 15.7%, 13.6%, 10.8% and 7.3% of high-grade serous carcinomas. In contrast, we did not observe high level of ERBB2 amplification in any of the samples. Low-grade tumors did not show DNA copy number gain in any of the loci, except in 2 (8%) of 24 low-grade tumors showing low copy number gain in the Notch3 locus. Taken together, our results provide the first comprehensive analysis of DNA copy number changes in highly pure ovarian serous carcinoma. These findings may have important biological and clinical implications.

AB - Ovarian serous carcinoma is the most common and lethal type of ovarian cancer and its molecular etiology remains poorly understood. As an ongoing effort to elucidate the pathogenesis of ovarian serous carcinomas, we assessed the DNA copy number changes in 33 high-grade serous carcinomas and 10 low-grade serous tumors by using a genome-wide technique, single nucleotide polymorphism array, performed on affinity-purified tumor cells from fresh surgical specimens. Compared to low-grade tumors, high-grade serous carcinomas showed widespread DNA copy number changes. The most frequent alterations were in loci harboring candidate oncogenes: cyclin E1 (CCNE1), AKT2, Notch3 and PIK3CA as well as in novel loci, including 12p13, 8q24, 12p13 and 12q15. Seven amplicons were selected for dual color fluorescence in situ hybridization analysis in ∼90 high-grade serous carcinomas and 26 low-grade serous tumors, and a high level of DNA copy number gain (amplification) was found in CCNE1, Notch3, HBXAP/Rsf-1, AKT2, PIK3CA and chr12p13 occurring in 36.1%, 7.8%, 15.7%, 13.6%, 10.8% and 7.3% of high-grade serous carcinomas. In contrast, we did not observe high level of ERBB2 amplification in any of the samples. Low-grade tumors did not show DNA copy number gain in any of the loci, except in 2 (8%) of 24 low-grade tumors showing low copy number gain in the Notch3 locus. Taken together, our results provide the first comprehensive analysis of DNA copy number changes in highly pure ovarian serous carcinoma. These findings may have important biological and clinical implications.

KW - Amplification

KW - Genetics

KW - Karyotyping

KW - Oncogene

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=34247469336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247469336&partnerID=8YFLogxK

U2 - 10.1002/ijc.22609

DO - 10.1002/ijc.22609

M3 - Article

C2 - 17351921

AN - SCOPUS:34247469336

VL - 120

SP - 2613

EP - 2617

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 12

ER -